Original Research

Published on 07 Dec 2022

First-line sintilimab plus chemotherapy in locally advanced or metastatic esophageal squamous cell carcinoma: A cost-effectiveness analysis from China

in Drugs Outcomes Research and Policies

Jian Shen
Yi Du
Rong Shao
Rong Jiang

Frontiers in Pharmacology

doi 10.3389/fphar.2022.967182

2,127 views
14 citations

Systematic Review

Published on 07 Dec 2022

Effect of aspirin in patients with established asymptomatic carotid atherosclerosis: A systematic review and meta-analysis

in Drugs Outcomes Research and Policies

Xianjin Hu
Yao Hu
Xiankun Sun
Ying Li
Ye Zhu

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1041400

9,875 views
7 citations

Original Research

Published on 06 Dec 2022

Generic switching: Do future physicians in Jordan have enough knowledge and a positive attitude?

in Drugs Outcomes Research and Policies

Sura Al Zoubi
Lobna Gharaibeh
Batool Al-Masri
Ahmad B. Alsahele
Buthainah AL-Masaeid

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1037112

1,977 views
2 citations

Systematic Review

Published on 05 Dec 2022

Decrementally cost-effective health technologies in non-inferiority studies: A systematic review

in Drugs Outcomes Research and Policies

Meryl Darlington
Raffaele Scarica
Xyomara Chavez-Pacheco
Laeticia Blamplain Segar
Isabelle Durand-Zaleski

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1025326

2,423 views
1 citation

Systematic Review

Published on 01 Dec 2022

Efficacy and safety of the dexamethasone implant in vitrectomized and nonvitrectomized eyes with diabetic macular edema: A systematic review and meta-analysis

in Drugs Outcomes Research and Policies

Qiongzhen Yuan
Yanling Liu
Yueqin Gou
Hanyue Xu
Yunxia Gao
Yilin Liu
Yi Chen
Ming Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1029584

2,227 views
2 citations

Original Research

Published on 01 Dec 2022

Exploring the prevalence and characteristics of adverse drug events among older adults in South Korea using a national health insurance database

in Drugs Outcomes Research and Policies

Eunkyeong Choi
Siin Kim
Hae Sun Suh

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1047387

2,746 views
3 citations

Original Research

Published on 01 Dec 2022

Post-marketing safety of immunomodulatory drugs in multiple myeloma: A pharmacovigilance investigation based on the FDA adverse event reporting system

in Drugs Outcomes Research and Policies

Tingting Jiang
Hui Su
Yanping Li
Yuanlin Wu
Yue Ming
Chen Li
Ruoqiu Fu
Lu Feng
Ziwei Li
Li Li

Frontiers in Pharmacology

doi 10.3389/fphar.2022.989032

4,014 views
6 citations

Review

Published on 28 Nov 2022

Drug-induced liver injury in COVID-19 treatment: Incidence, mechanisms and clinical management

in Drugs Outcomes Research and Policies

Xichuan Li
Wanting Wang
Suying Yan
Weipeng Zhao
Hui Xiong
Cuiping Bao
Jinqian Chen
Yuan Yue
Yanjun Su
Chunze Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1019487

9,256 views
9 citations

Original Research

Published on 28 Nov 2022

Community pharmacists’ views and experiences toward over-the-counter medicines misuse and abuse in Saudi Arabia: A qualitative study

in Drugs Outcomes Research and Policies

Mohammad Algarni
Zahraa Jalal
Muhammad Abdul Hadi
Saleh Alghamdi

Frontiers in Pharmacology

doi 10.3389/fphar.2022.997342

6,929 views
4 citations

Review

Published on 28 Nov 2022

Immunotherapy and targeted therapy for lung cancer: Current status and future perspectives

in Drugs Outcomes Research and Policies

Bilal Zulfiqar
Asim Farooq
Shahzina Kanwal
Kashif Asghar

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1035171

11,840 views
21 citations

Original Research

Published on 28 Nov 2022

Cost-Effectiveness Analysis of Sintilimab Combined with Chemotherapy Versus Chemotherapy Alone as the First-Line Treatment for Advanced Esophageal Cancer

in Drugs Outcomes Research and Policies

Zhuo-Miao Ye
Zhe Xu
Fan-Yuan Zeng
Zi-Qing Tang
Qin Zhou

Frontiers in Pharmacology

doi 10.3389/fphar.2022.934275

2,286 views
6 citations

Editorial

Published on 25 Nov 2022

Editorial: Rising stars in drugs outcomes research and policies: 2021

in Drugs Outcomes Research and Policies

Robert L. Lins
Fariba Ahmadizar
Tanveer Khan

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1076513

1,644 views

Original Research

Published on 25 Nov 2022

Assessment of the effectiveness and efficiency of the West Africa medicines regulatory harmonization initiative by the member countries

in Drugs Outcomes Research and Policies

Mercy Owusu-Asante
Delese Mimi Darko
Stuart Walker
Sam Salek

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1069345

3,309 views
7 citations

Original Research

Published on 24 Nov 2022

Medication non-adherence and associated factors among older adult stroke survivors in China

in Drugs Outcomes Research and Policies

Wenjing Cao
Azidah Abdul Kadir
Juan Wang
Lin Hu
Linlan Wen
Mei Yu
Liqun Peng
Lanying Chen
Na Luo
Intan Idiana Hassan

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1054603

3,383 views
8 citations

Perspective

Published on 24 Nov 2022

The impact of the war on maintenance of long-term therapies in Ukraine

in Drugs Outcomes Research and Policies

Nataliia Khanyk
Bohdan Hromovyk
Oksana Levytska
Tamas Agh
Björn Wettermark
Przemyslaw Kardas

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1024046

9,043 views
24 citations

Editorial

Published on 24 Nov 2022

Editorial: The use of real world data for regulatory purposes in the rare diseases setting

in Drugs Outcomes Research and Policies

Viviana Giannuzzi
Violeta Stoyanova-Beninska
Virginie Hivert

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1089033

2,512 views
3 citations

Navigation group

Articles

First-line sintilimab plus chemotherapy in locally advanced or metastatic esophageal squamous cell carcinoma: A cost-effectiveness analysis from China

Effect of aspirin in patients with established asymptomatic carotid atherosclerosis: A systematic review and meta-analysis

Generic switching: Do future physicians in Jordan have enough knowledge and a positive attitude?

Decrementally cost-effective health technologies in non-inferiority studies: A systematic review

Efficacy and safety of the dexamethasone implant in vitrectomized and nonvitrectomized eyes with diabetic macular edema: A systematic review and meta-analysis

Exploring the prevalence and characteristics of adverse drug events among older adults in South Korea using a national health insurance database

Post-marketing safety of immunomodulatory drugs in multiple myeloma: A pharmacovigilance investigation based on the FDA adverse event reporting system

Drug-induced liver injury in COVID-19 treatment: Incidence, mechanisms and clinical management

Community pharmacists’ views and experiences toward over-the-counter medicines misuse and abuse in Saudi Arabia: A qualitative study

Immunotherapy and targeted therapy for lung cancer: Current status and future perspectives

Cost-Effectiveness Analysis of Sintilimab Combined with Chemotherapy Versus Chemotherapy Alone as the First-Line Treatment for Advanced Esophageal Cancer

Editorial: Rising stars in drugs outcomes research and policies: 2021

Assessment of the effectiveness and efficiency of the West Africa medicines regulatory harmonization initiative by the member countries

Medication non-adherence and associated factors among older adult stroke survivors in China

The impact of the war on maintenance of long-term therapies in Ukraine

Editorial: The use of real world data for regulatory purposes in the rare diseases setting